Website maintenance is scheduled for Saturday, October 12, and Sunday, October 13. Short disruptions may occur during these days.

brand logo

Am Fam Physician. 2023;107(5):online

Author disclosure: No relevant financial relationships.

Details for This Review

Study Population: 1,818 adults with alcohol use disorder in 17 randomized controlled trials; the mean age was 46.5 years, and 70% were men

Efficacy End Points: Relapse, frequency of alcohol use, amount of alcohol use

Harm End Points: Adverse events

BenefitsHarms
In patients who completed baclofen treatment compared with placebo:
 1 in 10 had a reduced risk of relapse (i.e., return to any drinking)
 Abstinent days increased by 17%
 No overall increase in the number of adverse events
Minor adverse events in patients with alcohol use disorder who were treated with baclofen compared with placebo:
 1 in 10 had dizziness
 1 in 35 had dry mouth
 1 in 12 had fatigue
 1 in 5 had paresthesias
 1 in 9 had somnolence

Narrative: Alcohol use disorder is characterized by the inability to control alcohol consumption and frequent drinking episodes leading to clinically significant impairment or distress.1,2 In U.S. adults, alcohol use disorder has a 12-month prevalence of 13.9% and a lifetime prevalence of 29.1%.3 Alcohol use disorder increases the risk of cancer, liver disease, cardiac disease, unintentional accidents, and neurologic conditions.4 Treatment options supported by the American Psychiatric Association include individualized plans that focus on nonpharmacologic approaches (including cognitive behavior therapy and 12-step therapies such as Alcoholics Anonymous) and pharmacotherapy. Pharmacologic options include opioid antagonists (naltrexone, nalmefene), glutamate antagonists (acamprosate), aversive agents (disulfiram), and anticonvulsants (gabapentin, topiramate).5

Already a member/subscriber?  Log In

Subscribe

From $165
  • Immediate, unlimited access to all AFP content
  • More than 130 CME credits/year
  • AAFP app access
  • Print delivery available
Subscribe

Issue Access

$59.95
  • Immediate, unlimited access to this issue's content
  • CME credits
  • AAFP app access
  • Print delivery available
Purchase Access:  Learn More

Copyright ©2024 MD Aware, LLC (theNNT.com). Used with permission.

This series is coordinated by Christopher W. Bunt, MD, AFP assistant medical editor, and the NNT Group.

A collection of Medicine by the Numbers published in AFP is available at https:// www.aafp.org/afp/mbtn.

Continue Reading

More in AFP

More in PubMed

Copyright © 2023 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.